Results 31 to 40 of about 494,883 (340)

Dialysis solution containing hyaluronan: Effect on peritoneal permeability and inflammation in rats [PDF]

, 2000
Dialysis solution containing hyaluronan: Effect on peritoneal permeability and inflammation in rats.BackgroundHyaluronan (HA), a high molecular weight mucopolysaccharide found in interstitial tissues and fluid, is lost from the peritoneal cavity during ...
Breçborowicz, Andrzej, Chen, Chi, Kużlan-Pawlaczyk, Małgorzata, Martis, L., Moberly, James B., Oreopoulos, Dimitrios G., Pawlaczyk, Krzystof, Połubinska, Alicja, Wieczorowska-Tobis, Katarzyna   +8 more
core   +1 more source

Comparison of peritoneal dialysis and hemodialysis as first renal replacement therapy in patients with end-stage renal disease and diabetes: a systematic review

Renal Replacement Therapy, 2019
Background Diabetes has become the most common cause of end-stage renal disease (ESRD) requiring renal replacement therapy (RRT) in most countries around the world.
Yukio Maruyama, Chieko Higuchi, Hiroaki Io, Keiichi Wakabayashi, Hiraku Tsujimoto, Yasushi Tsujimoto, Hidemichi Yuasa, Munekazu Ryuzaki, Yasuhiko Ito, Hidetomo Nakamoto   +9 more
doaj   +1 more source

Ultrastructural changes of the peritoneum in a rabbit model of peritoneal dialysis [PDF]

, 2013
Background/Aim. The number of patients with end-stage renal diseases treated with chronic dialysis is increasing over the last years. Long-term peritoneal dialysis is associated with progressive development of structural and functional alterations of ...
Jovanović Nataša, Krstić Slobodan, Laušević Željko, Oprić Dejan, Stojimirović Biljana, Trbojević-Stanković Jasna, Trpinac Dušan, Žunić-Božinovski Snežana   +7 more
core   +1 more source

Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report

BMC Nephrology, 2018
Background Icodextrin is a starch-derived, water soluble glucose polymer, which is used as an alternative to glucose in order to enhance dialytic fluid removal in peritoneal dialysis patients.
Vassilios Liakopoulos, Panagiotis I Georgianos, Paraskevi Demirtzi, Vasilios Vaios, Theofanis Kalathas, Pantelis E Zebekakis   +5 more
doaj   +1 more source

Educating end-stage renal disease patients on dialysis modality selection: a clinical advice from the European Renal Best Practice (ERBP) advisory board [PDF]

, 2010
status ...
Bammens, Bert, Covic, Adrian, Fouque, Denis, Heimbürger, Olof, Lobbedez, Thierry, Segall, Liviu, Van Biesen, Wim, Vanholder, Raymond   +7 more
core   +2 more sources

A comparison of transplant outcomes in peritoneal and hemodialysis patients [PDF]

, 2002
A comparison of transplant outcomes in peritoneal and hemodialysis patients.BackgroundStudies examining the effect of pre-transplant dialysis modality on graft and patient survival after kidney transplantation have produced conflicting results. Therefore,
Collins, Allan J., Gilbertson, David T., Kasiske, Bertram L., Snyder, Jon J.   +3 more
core   +1 more source

Calciphylaxis: A successful outcome whilst on peritoneal dialysis

Bulletin de la Dialyse à Domicile, 2019
Calciphylaxis is a life threatening disease for which patients with chronic kidney disease, particular those on dialysis, are at increased risk. As it is a rare condition, treatment options are limited and duration of treatment is not clear, especially ...
Ana Gaspar, Luis Falcão, Sofia Correia, Maria João Carvalho, Anabela Rodrigues, Antonio Cabrita   +5 more
doaj   +1 more source

Adipose and serum zinc alpha-2-glycoprotein (ZAG) expressions predict longitudinal change of adiposity, wasting and predict survival in dialysis patients

Scientific Reports, 2022
There were limited data on adipose and serum zinc alpha-2-glycoprotein (ZAG) expression and its association with body composition in patients with advanced chronic kidney disease (CKD).
Gordon Chun-Kau Chan, Win Hlaing Than, Bonnie Ching-Ha Kwan, Ka-Bik Lai, Ronald Cheong-Kin Chan, Jeremy Yuen-Chun Teoh, Jack Kit-Chung Ng, Kai-Ming Chow, Winston Wing-Shing Fung, Phyllis Mei-Shan Cheng, Man-Ching Law, Chi-Bon Leung, Philip Kam-Tao Li, Cheuk-Chun Szeto   +13 more
doaj   +1 more source

Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy. [PDF]

, 2020
Intraperitoneal vancomycin is the first-line therapy in the management of peritoneal dialysis (PD)-related peritonitis. However, due to the paucity of data, vancomycin dosing for peritonitis in patients on automated peritoneal dialysis (APD) is empiric ...
Kraft, Walter K., Lam, Edwin, Lien, Yi Ting Kayla, Piraino, Beth, Schmidt, Stephan, Vozmediano, Valvanera, Zhang, Jingjing   +6 more
core   +1 more source

Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes [PDF]

, 2017
Peritonitis remains the major obstacle for the maintenance of long-term peritoneal dialysis and dysregulated host peritoneal immune responses may compromise local anti-infectious defense, leading to treatment failure.
Andreesen, Ann Kift-Morgan, Aziz, Bellon, Brown, Chia-Te Liao, Davies, Davies, Dioszeghy, Donald J. Fraser, Fakhri, Fielding, Ganguly, Gautier, Geissmann, Gordon, Guilliams, Hume, Hurst, Leah E. Wallace, Li, Liao, Lin, Lin, Malik, McCully, McGregor, McGregor, McLoughlin, Meuter, Mohd Wajid A. Khan, Mokoena, Nicholas Topley, Noorman, Perl, Peterson, Philip R. Taylor, Reimold, Robert Andrews, Roberts, Rosas, Rosas, Sanchez-Sanchez, Satpathy, Segura, Suzuki, Tamoutounour, Verbrugh, Villadangos, Waskow, Xu   +50 more
core   +2 more sources